ENTITY
Cathay Biotech

Cathay Biotech (688065 CH)

39
Analysis
MaterialsChina
Cathay Biotech Inc. engages in synthetic biology, producing new materials on an industrial scale through bio-manufacturing. The Company focuses on polyamide industry's value chain covering biological long-chain dibasic acid, bio-based pentane diamine, bio-based polyamide, and more. Cathay Biotech markets its products worldwide.
more
14 Nov 2023 05:30

CSI300 Index Rebalance Preview: 13 Potential Changes in December

There could be 13 changes for the CSI300 in Dec. With an increase in tracking AUM, there are many stocks with over 1x ADV to trade. Adds, deletes...

Logo
880 Views
Share
17 Sep 2023 06:01

Quiddity Leaderboard CSI 300/​​500 Dec 23:  US$2.8bn One-Way; Might Be Time for a Basket Trade

The Names directly moving into CSI 300 and CSI 500 without previously being members of either of these indices could outperform the CSI 300 index...

Share
11 Sep 2023 07:00

CSI500 Index Rebalance Preview: ETF Inflows Lead to Performance Skew

There should be 50 changes in Dec with a big sector skew. Turnover is ~10% and 31 stocks will have 1x ADV to trade. Huge ETF inflows have led to...

Logo
724 Views
Share
bullishLasertec Corp
10 Sep 2023 06:30

Index Rebalance & ETF Flow Recap: NKY, ASX, CSI300, KOSDAQ150, Yuanta ETFs, MVA, MVW, SMH

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
701 Views
Share
07 Sep 2023 08:26

CSI300 Index Rebalance Preview: 14 Potential Changes in December

There could be 14 changes for the CSI300 in Dec. We estimate one-way turnover of 1.93% and one-way trade of CNY 6.93bn. Materials lose the most...

Logo
815 Views
Share
x